PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 134 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q1 2020. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $241,504 | -42.8% | 29,380 | -69.2% | 0.00% | -100.0% |
| Q2 2022 | $422,000 | -52.2% | 95,454 | -1.5% | 0.00% | 0.0% |
| Q1 2022 | $883,000 | +0.3% | 96,953 | +125.3% | 0.00% | 0.0% |
| Q4 2021 | $880,000 | -20.0% | 43,034 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $1,100,000 | +202.2% | 43,034 | +314.0% | 0.00% | – |
| Q2 2021 | $364,000 | -10.1% | 10,395 | -33.2% | 0.00% | -100.0% |
| Q4 2020 | $405,000 | +175.5% | 15,567 | -63.5% | 0.00% | – |
| Q2 2020 | $147,000 | +86.1% | 42,672 | +65.2% | 0.00% | – |
| Q1 2020 | $79,000 | +14.5% | 25,835 | +97.5% | 0.00% | – |
| Q4 2019 | $69,000 | -98.5% | 13,082 | -98.5% | 0.00% | -100.0% |
| Q3 2019 | $4,620,000 | -11.8% | 895,286 | +3.4% | 0.01% | -10.0% |
| Q2 2019 | $5,239,000 | +9784.9% | 865,958 | +6158.7% | 0.01% | – |
| Q4 2016 | $53,000 | – | 13,836 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madrone Advisors, LLC | 16,415,933 | $218,331,909 | 38.11% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,015,495 | $26,806,084 | 19.75% |
| Decheng Capital Management III (Cayman), LLC | 1,463,872 | $19,469,498 | 6.11% |
| Iron Triangle Partners LP | 2,400,000 | $31,920,000 | 4.27% |
| Jackson Square Partners, LLC | 8,517,624 | $113,284,399 | 3.30% |
| BOURNE LENT ASSET MANAGEMENT INC | 580,000 | $7,714,000 | 2.69% |
| ARK Investment Management | 26,634,620 | $354,240,443 | 2.34% |
| ARDSLEY ADVISORY PARTNERS LP | 906,000 | $12,049,800 | 2.04% |
| Avidity Partners Management LP | 4,337,400 | $57,687,420 | 2.02% |
| Nikko Asset Management Americas, Inc. | 13,649,948 | $181,271,309 | 1.91% |